Casein kinase II is a selective target of HIV-1 transcriptional inhibitors
Open Access
- 10 June 1997
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 94 (12), 6110-6115
- https://doi.org/10.1073/pnas.94.12.6110
Abstract
The identification of cellular factors that are required to complete various steps of the HIV-1 life cycle may lead to the development of new therapeutics. One key step, transcription from the integrated provirus, is inhibited by members of two distinct classes of compounds, the flavonoids and the benzothiophenes, via an unknown mechanism, possibly involving a cellular factor. A marked specificity toward inhibiting HIV-1 transcription is evidenced by the ability of drug-treated cells to retain their proliferative and differentiation capabilities. In addition, the compounds do not impede the activation and function of the transcriptional factor NF-κB. Here we report on the identification of several cellular proteins that mediate the HIV-1 transcriptional inhibitory property of the flavonoid chrysin. Chemical and immunologic analyses identified these cellular proteins as the individual subunits of casein kinase II (CKII). Though structurally unrelated to chrysin, an HIV-1 inhibitory benzothiophene also bound selectively to CKII. Both chrysin and the benzothiophenes inhibited human recombinant CKII enzymatic activity and showed competitive kinetics with respect to ATP, analogous to the classic CKII inhibitor 5,6-dichloro-1-β-d-ribofuranosylbenzimidazole (DRB). Moreover, DRB potently inhibited HIV-1 expression in chronically infected cells. CKII may regulate HIV-1 transcription by phosphorylating cellular proteins involved in HIV-1 transactivation that contain multiple CKII phosphorylation consensus sequences.Keywords
This publication has 64 references indexed in Scilit:
- Host factors and the pathogenesis of HIV-induced diseaseNature, 1996
- Characterization of IκB KinasesPublished by Elsevier BV ,1996
- Identification of a Group of Cellular Cofactors That Stimulate the Binding of RNA Polymerase II and TRP-185 to Human Immunodeficiency Virus 1 TAR RNAJournal of Biological Chemistry, 1996
- Casein kinase II is the P protein phosphorylating cellular kinase associated with the ribonucleoprotein complex of purified vesicular stomatitis virusJournal of General Virology, 1995
- Construction andIn VitroProperties of HIV-1 Mutants with Deletions in "Nonessential" GenesAIDS Research and Human Retroviruses, 1994
- Biosynthesis of casein kinase II in lymphoid cell linesEuropean Journal of Biochemistry, 1994
- The Human Immunodeficiency Virus Type 1 Encoded Vpu Protein is Phosphorylated by Casein Kinase-2 (CK-2) at Positions Ser52 and Ser56 within a Predicted α-Helix-Turn-α-Helix-MotifJournal of Molecular Biology, 1994
- Blocking of Tat-dependent HIV-1 RNA modification by an inhibitor of RNA polymerase II processivityNature, 1991
- Tat and RevAIDS, 1990
- Altered protein kinase activities of lymphoid cells transformed by Abelson and Moloney leukemia virusesFEBS Letters, 1986